Addiction and substance abuse

1010 WINS Newsroom
December 16, 2019 - 4:41 pm
RENTON, Wash. (AP) — The NFL has suspended indefinitely Seahawks wide receiver Josh Gordon for violating league policies on performance enhancers. Gordon was reinstated by the NFL in August after having been suspended indefinitely in December 2018, missing the final three games of last season for...
Read More
1010 WINS Newsroom
December 16, 2019 - 4:33 pm
Read More
This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker)
1010 WINS Newsroom
December 15, 2019 - 10:06 pm
The gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said. Some conference attendees were stunned when they saw the company logo: Mundipharma, the...
Read More
In this Thursday, Oct. 31, 2019, photo, a recovering tramadol user waits for her medication at a de-addiction center in Kapurthala, in the northern Indian state of Punjab. The pills were everywhere, as legitimate medication sold in pharmacies, but also illicit counterfeits hawked by itinerant peddlers and street vendors. India has twice the global average of illicit opiate consumption. Researchers estimate about 4 million Indians use heroin or other opioids, and a quarter of them live in the Punjab, India's agricultural heartland bordering Pakistan. (AP Photo/Channi Anand)
1010 WINS Newsroom
December 13, 2019 - 3:23 pm
KAPURTHALA, India (AP) — Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists. These pills, the world has been told, are safer than the OxyContins, the Vicodins, the fentanyls that have wreaked so much...
Read More
In this Sunday, Oct. 20, 2019 photo, Rev. William Tourigny, 66, pastor of St. Rose de Lima Parish, in Chicopee, Mass., arranges vestments while preparing to offer Mass at the Catholic church. When Tourigny was ordained in 1980, the Springfield diocese had more than 300 priests serving 136 parishes. Since then, the ranks of priests have shrunk by more than half and nearly 60 of the parishes have closed. For Tourigny, it's meant many more funerals to handle, including dozens related to drug overdoses and heavy drinking. (AP Photo/Steven Senne)
1010 WINS Newsroom
December 09, 2019 - 1:13 pm
CHICOPEE, Mass. (AP) — More than a century ago, waves of Catholic immigrants from Ireland, Poland and Quebec settled in Chicopee and other western Massachusetts mill towns, helping build churches, rectories and schools to accommodate their faith. Today the priests leading those churches are under...
Read More
Counselor to the President Kellyanne Conway, participates in a roundtable discussion on the opioid crisis, on Capitol Hill in Washington, Wednesday, Oct. 23, 2019. (AP Photo/Cliff Owen)
1010 WINS Newsroom
October 30, 2019 - 5:14 am
WASHINGTON (AP) — The Trump administration has unveiled a website aimed at helping millions of Americans with substance abuse issues learn about and locate treatment options. FindTreatment.gov is the latest development in the administration's effort to address the nation's opioid crisis. The White...
Read More
Attorney Mark Lanier gets a hug outside the U.S. Federal courthouse, Monday, Oct. 21, 2019, in Cleveland. The nation's three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday. (AP Photo/Tony Dejak)
1010 WINS Newsroom
October 21, 2019 - 5:22 pm
CLEVELAND (AP) — The nation's three biggest drug distributors and a major drugmaker agreed to an 11th-hour, $260 million settlement Monday over the terrible toll taken by opioids in two Ohio counties, averting the first federal trial over the crisis. The trial, involving Cleveland's Cuyahoga County...
Read More
1010 WINS Newsroom
October 09, 2019 - 11:48 pm
ANCHORAGE, Alaska (AP) — An Alaska doctor and nurse practitioner face federal charges of illegally distributing millions of opioid doses to patients that resulted in addiction, overdoses and deaths, officials said. The Alaska U.S. attorney announced Wednesday that 48-year-old Jessica Joyce Spayd...
Read More
FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
1010 WINS Newsroom
October 06, 2019 - 3:50 pm
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
CORRECTS STATE TO OHIO NOT PENNSYLVANIA - Narcotics detective Ben Hill, with the Barberton Police Department, shows two bags of medications that are are stored in their headquarters and slated for destruction, Wednesday, Sept. 11, 2019, in Barberton, Ohio. Attorneys representing some 2,000 local governments said Wednesday they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis. (AP Photo/Keith Srakocic)
1010 WINS Newsroom
September 11, 2019 - 7:51 pm
HARTFORD, Conn. (AP) — A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation's opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue against the company and...
Read More

Pages